203 related articles for article (PubMed ID: 25219505)
1. Improving on nature: making a cyclic heptapeptide orally bioavailable.
Nielsen DS; Hoang HN; Lohman RJ; Hill TA; Lucke AJ; Craik DJ; Edmonds DJ; Griffith DA; Rotter CJ; Ruggeri RB; Price DA; Liras S; Fairlie DP
Angew Chem Int Ed Engl; 2014 Nov; 53(45):12059-63. PubMed ID: 25219505
[TBL] [Abstract][Full Text] [Related]
2. Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides.
Nielsen DS; Lohman RJ; Hoang HN; Hill TA; Jones A; Lucke AJ; Fairlie DP
Chembiochem; 2015 Nov; 16(16):2289-93. PubMed ID: 26336864
[TBL] [Abstract][Full Text] [Related]
3. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.
Rezai T; Yu B; Millhauser GL; Jacobson MP; Lokey RS
J Am Chem Soc; 2006 Mar; 128(8):2510-1. PubMed ID: 16492015
[TBL] [Abstract][Full Text] [Related]
4. Orally Absorbed Cyclic Peptides.
Nielsen DS; Shepherd NE; Xu W; Lucke AJ; Stoermer MJ; Fairlie DP
Chem Rev; 2017 Jun; 117(12):8094-8128. PubMed ID: 28541045
[TBL] [Abstract][Full Text] [Related]
5. Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure.
Fouché M; Schäfer M; Berghausen J; Desrayaud S; Blatter M; Piéchon P; Dix I; Martin Garcia A; Roth HJ
ChemMedChem; 2016 May; 11(10):1048-59. PubMed ID: 27154275
[TBL] [Abstract][Full Text] [Related]
6. Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products.
Bockus AT; Lexa KW; Pye CR; Kalgutkar AS; Gardner JW; Hund KC; Hewitt WM; Schwochert JA; Glassey E; Price DA; Mathiowetz AM; Liras S; Jacobson MP; Lokey RS
J Med Chem; 2015 Jun; 58(11):4581-9. PubMed ID: 25950816
[TBL] [Abstract][Full Text] [Related]
7. Improving oral bioavailability of cyclic peptides by N-methylation.
Räder AFB; Reichart F; Weinmüller M; Kessler H
Bioorg Med Chem; 2018 Jun; 26(10):2766-2773. PubMed ID: 28886995
[TBL] [Abstract][Full Text] [Related]
8. Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients.
Wang CK; Northfield SE; Colless B; Chaousis S; Hamernig I; Lohman RJ; Nielsen DS; Schroeder CI; Liras S; Price DA; Fairlie DP; Craik DJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17504-9. PubMed ID: 25416591
[TBL] [Abstract][Full Text] [Related]
9. Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability.
Wang CK; Northfield SE; Swedberg JE; Colless B; Chaousis S; Price DA; Liras S; Craik DJ
Eur J Med Chem; 2015 Jun; 97():202-13. PubMed ID: 25974856
[TBL] [Abstract][Full Text] [Related]
10. Intestinal permeability of cyclic peptides: common key backbone motifs identified.
Beck JG; Chatterjee J; Laufer B; Kiran MU; Frank AO; Neubauer S; Ovadia O; Greenberg S; Gilon C; Hoffman A; Kessler H
J Am Chem Soc; 2012 Jul; 134(29):12125-33. PubMed ID: 22737969
[TBL] [Abstract][Full Text] [Related]
11. On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.
White TR; Renzelman CM; Rand AC; Rezai T; McEwen CM; Gelev VM; Turner RA; Linington RG; Leung SS; Kalgutkar AS; Bauman JN; Zhang Y; Liras S; Price DA; Mathiowetz AM; Jacobson MP; Lokey RS
Nat Chem Biol; 2011 Sep; 7(11):810-7. PubMed ID: 21946276
[TBL] [Abstract][Full Text] [Related]
12. On the transferability of atomic solvation parameters: Ab initio structural prediction of cyclic heptapeptides in DMSO.
Baysal C; Meirovitch H
Biopolymers; 2000 Nov; 54(6):416-28. PubMed ID: 10951328
[TBL] [Abstract][Full Text] [Related]
13. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.
Rezai T; Bock JE; Zhou MV; Kalyanaraman C; Lokey RS; Jacobson MP
J Am Chem Soc; 2006 Nov; 128(43):14073-80. PubMed ID: 17061890
[TBL] [Abstract][Full Text] [Related]
14. NMR and computer-aided modeling studies of the interactions between a cyclic hexapeptide and the two enantiomers of some Boc- and Fmoc-amino acids.
McEwen I
Biopolymers; 1993 Jun; 33(6):933-42. PubMed ID: 8318666
[TBL] [Abstract][Full Text] [Related]
15. Postsynthetic modification of C3-symmetric aza-beta3-cyclohexapeptides.
Le Grel P; Salaün A; Mocquet C; Le Grel B; Roisnel T; Potel M
J Org Chem; 2008 Feb; 73(4):1306-10. PubMed ID: 18197679
[TBL] [Abstract][Full Text] [Related]
16. Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets.
Naylor MR; Bockus AT; Blanco MJ; Lokey RS
Curr Opin Chem Biol; 2017 Jun; 38():141-147. PubMed ID: 28570865
[TBL] [Abstract][Full Text] [Related]
17. Design Principles for Intestinal Permeability of Cyclic Peptides.
Mathiowetz AM
Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
[TBL] [Abstract][Full Text] [Related]
18. Comparison of helix-stabilizing effects of alpha,alpha-dialkyl glycines with linear and cycloalkyl side chains.
Vijayalakshmi S; Rao RB; Karle IL; Balaram P
Biopolymers; 2000 Jan; 53(1):84-98. PubMed ID: 10644953
[TBL] [Abstract][Full Text] [Related]
19. Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues.
Bockus AT; Schwochert JA; Pye CR; Townsend CE; Sok V; Bednarek MA; Lokey RS
J Med Chem; 2015 Sep; 58(18):7409-18. PubMed ID: 26308180
[TBL] [Abstract][Full Text] [Related]
20. De novo development of small cyclic peptides that are orally bioavailable.
Merz ML; Habeshian S; Li B; David JGL; Nielsen AL; Ji X; Il Khwildy K; Duany Benitez MM; Phothirath P; Heinis C
Nat Chem Biol; 2024 May; 20(5):624-633. PubMed ID: 38155304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
